Login

David Allmond, CEO, Novacyt 00:00:00

Share On Facebook Share On Twitter

David Allmond: Discussing future infectious disease threats

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Insights into Strategic Asset Allocation: Evaluating BBVA Asset Management's Positioning from 2021 to 2022"
00:10:00
Are Regulators Shaping Fintech Investment Terms? Exploring Neobank Fundraising Trends | John Slate - Founder of Skadden
00:10:00
10 Common Questions About Audits
00:10:00
Exploring Lithium and Gold: Simon Discusses Company Strategy at One-to-One Mining Conference
00:10:00
Robert Ogór on AMBRA SA's Wine Market Strategy and Increased Dividend Expectations | Robert Ogór, President, AMBRA SA.
00:10:00
The Growth Engine: A Systematic Approach to User Acquisition|Brian Balfour,Venture Partner,Long Journey Ventures
00:10:00
The Cult of Carl Schmitt: A Critical Examination|Richard Wolin,Professor,City University of New York
00:10:00
Biopharmaceutical CEO discusses promising Phase 3 trial results of a novel antibiotic for Clostridioides difficile Infections with potential market impact exceeding $1B |David P Luci , CEO, Acurx Pharmaceuticals Inc.
00:10:00
Biofuels: A Sunshine Opportunity for the Green Growth|Marilyn Bruno , CEO of Aequor Inc
00:10:00
Family Finance: A Team Sport | Jenn Steliga - Advisor of Time Well Spent Financial Coaching LLC
00:10:00
Transforming Nigeria's Iron Ore Sector: Colby Iron Limited at the One-to-One Mining Investment Conference
00:10:00
We talk to Vince Hawksworth, CEO of Mercury, about the challenges of becoming CEO and his support for the Multiple Sclerosis Society of New Zealand.

© 2026 Nehu